Dr. Shazia Mirza is a Grapevine, Texas based neurologist who is specialized in Neurology. Active license number of Dr. Shazia Mirza is S3715 for Neurology in Texas. Her current practice location is 1650 W College St, Grapevine. Patients can reach her at 817-481-1588. Dr. Shazia Mirza NPI number (Unique professional ID assigned by NPPES) is 1750812970. Dr. Shazia Mirza specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Shazia Mirza speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Shazia Mirza
Specialization:
Neurology
Gender:
Female
Practice Address:
1650 W College St, Grapevine, Texas, 76051-3565
Phone:
817-481-1588
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1750812970
NPI Enumeration Date:
21 Mar, 2017
NPI Last Update On:
08 Nov, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Shazia Mirza are as mentioned below.
License Number
Specialization
State
Status
S3715
Neurology
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Shazia Mirza 1650 W College St # 150, Grapevine, Texas
Zip:
76051-3565
Patients can reach Dr. Shazia Mirza at 1650 W College St, Grapevine, Texas or can call to book an appointment on 817-481-1588.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.